Annual ROE:
-61.90%+7.22%(+10.45%)Summary
- As of today, RXRX annual return on equity is -61.90%, with the most recent change of +7.22% (+10.45%) on December 31, 2024.
- During the last 3 years, RXRX annual ROE has fallen by -14.39% (-30.29%).
- RXRX annual ROE is now -32.95% below its all-time high of -46.56%, reached on December 31, 2022.
Performance
RXRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-81.20%+1.41%(+1.71%)Summary
- As of today, RXRX quarterly return on equity is -81.20%, with the most recent change of +1.41% (+1.71%) on June 30, 2025.
- Over the past year, RXRX quarterly ROE has dropped by -1.63% (-2.05%).
- RXRX quarterly ROE is now -373.49% below its all-time high of 29.69%, reached on December 1, 2020.
Performance
RXRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RXRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +10.4% | -2.0% |
| 3Y3 Years | -30.3% | -88.6% |
| 5Y5 Years | +23.1% | - |
RXRX ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -33.0% | +10.4% | -61.9% | +1.7% |
| 5Y | 5-Year | -33.0% | +23.1% | -373.5% | +95.0% |
| All-Time | All-Time | -33.0% | +23.1% | -373.5% | +95.0% |
RXRX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -81.20%(+1.7%) |
| Mar 2025 | - | -82.61%(-7.2%) |
| Dec 2024 | -61.90%(+10.4%) | -77.06%(+1.6%) |
| Sep 2024 | - | -78.32%(+1.6%) |
| Jun 2024 | - | -79.57%(+1.1%) |
| Mar 2024 | - | -80.42%(-12.1%) |
| Dec 2023 | -69.12%(-48.5%) | -71.74%(-8.4%) |
| Sep 2023 | - | -66.16%(-12.5%) |
| Jun 2023 | - | -58.81%(-5.7%) |
| Mar 2023 | - | -55.66%(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -46.56%(+2.0%) | -51.00%(-1.7%) |
| Sep 2022 | - | -50.16%(-16.5%) |
| Jun 2022 | - | -43.06%(-1.4%) |
| Mar 2022 | - | -42.46%(-13.8%) |
| Dec 2021 | -47.51%(+12.9%) | -37.30%(-24.6%) |
| Sep 2021 | - | -29.94%(+83.6%) |
| Jun 2021 | - | -182.54%(+88.8%) |
| Mar 2021 | - | -1635.52%(-5608.7%) |
| Dec 2020 | -54.57%(+32.2%) | - |
| Dec 2020 | - | 29.69% |
| Dec 2019 | -80.53% | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual return on equity?
- What is the all-time high annual ROE for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of RXRX is -61.90%
What is the all-time high annual ROE for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual return on equity is -46.56%
What is Recursion Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, RXRX annual return on equity has changed by +7.22% (+10.45%)
What is Recursion Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of RXRX is -81.20%
What is the all-time high quarterly ROE for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly return on equity is 29.69%
What is Recursion Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, RXRX quarterly return on equity has changed by -1.63% (-2.05%)